홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Ketamine → Dopamine

HRID 1078539
인쇄

반응식

HRID 1078539 반응식
CNC1(C2C=CC=CC=2Cl)C(=O)CCCC1.CC1C=CC=C(C)C=1NC1SCCCN=1.CC(C1C=CC2SC3C=CC=CC=3N(CCCN(C)C)C=2C=1)=O.[CH:55]1[C:60]([OH:61])=[C:59]([OH:62])[CH:58]=[C:57](O)[C:56]=1[CH2:64][CH2:65][NH2:66].O=C1O[C@H]([C@H](CO)O)C(O)=C1O>>[NH2:66][CH2:65][CH2:64][C:56]1[CH:57]=[CH:58][C:59]([OH:62])=[C:60]([OH:61])[CH:55]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

6

반응물 5

HCID 3821KetamineHCID 46246-HydroxydopamineHCID 5707XylazineHCID 6077AcepromazineHCID 54670067L-Ascorbic Acid

생성물 1

HCID 681Dopamine

실험 절차

Rats were anesthetized with a 1.0 ml/kg intramuscular injection of a mixture of ketamine (33 mg/ml), xylazine (1.7 mg/ml), and acepromazine (10 mg/ml) and positioned in a Kopf stereotaxic instrument. A total of 12 μg of 6-OHDA (6 μl volume at a concentration of 2 μg/μl dissolved in 0.9% saline containing 0.2 μg/μl ascorbic acid) were infused at a rate of 1.0 μl/minute and allowed to diffuse for 5 minutes before the infusion cannula was slowly retracted. Infusion coordinates were 4.2 mm posterior to bregma, 1.0 mm lateral from midline, and 7.4 mm ventral to dura.

출처 및 근거

ORD 기록
ord-904a45114da049249fe459660907dbc1
출처 데이터셋
uspto-grants-1996_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05550050

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트